Patents by Inventor Simon John Hatch

Simon John Hatch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12622899
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Grant
    Filed: August 14, 2025
    Date of Patent: May 12, 2026
    Assignee: PureTech LYT 100, Inc.
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg, Yanqiong Zhang, Carol Ann Satler, David Andrew Golod
  • Publication number: 20250375431
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Application
    Filed: August 14, 2025
    Publication date: December 11, 2025
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg, Yanqiong Zhang, Carol Ann Satler, David Andrew Golod
  • Publication number: 20250114341
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidonc LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Application
    Filed: December 16, 2024
    Publication date: April 10, 2025
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg
  • Publication number: 20240358690
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Application
    Filed: June 28, 2024
    Publication date: October 31, 2024
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg